India Clarifies Recent NPPA Drug Pricing Reversal
This article was originally published in PharmAsia News
Executive Summary
India's National Pharmaceutical Pricing Authority retains the power to set price caps on drugs, but has just withdrawn internal May guidelines, the government said in an attempt to clarify recent action.